1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SUV39H2 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA PHLDA1 CTRPv2 pan-cancer AAC 0.096 0.01
mRNA JADE3 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA PUS10 CTRPv2 pan-cancer AAC -0.096 0.01
mRNA PLD6 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA ATP13A1 CTRPv2 pan-cancer AAC 0.097 0.01
mRNA AL135791.1 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA SPDYE2B CTRPv2 pan-cancer AAC 0.089 0.01
mRNA CNTROB CTRPv2 pan-cancer AAC -0.088 0.01
mRNA FBXL18 CTRPv2 pan-cancer AAC -0.092 0.01
Download CSV